Related Experiment Video

Updated: Oct 14, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

472

Obesity prevalence in celiac disease in the United States from 2014 to 2018

Alyssa Drosdak1,2, Sagarika Satyavada3, Mayada Ismail3

  • 1Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Addros014@gmail.com.

International Journal of Obesity (2005)
|November 7, 2021
PubMed

Insights

Obesity is increasingly prevalent in celiac disease (CD) patients. This study found rising obesity rates, particularly Class I, in adults diagnosed with CD between 2014 and 2018.

Area of Science:

  • Gastroenterology
  • Public Health
  • Epidemiology

Background:

  • Celiac disease (CD) is not typically linked with obesity.
  • However, a significant number of CD patients are overweight or obese at diagnosis.
  • Rising obesity rates in the general population necessitate an examination of obesity trends in CD patients.

Purpose of the Study:

  • To investigate the prevalence and trends of obesity among adult patients diagnosed with celiac disease in the United States from 2014 to 2018.

Main Methods:

  • Utilized a large electronic health record database from over 360 US hospitals.
  • Included adult patients diagnosed with CD between 2014 and 2018 who underwent esophagogastroduodenoscopy.
  • Analyzed obesity prevalence (BMI 30+) and categorized it into Class I, II, and III.

Main Results:

  • Identified 13,410 adult CD patients in the study period.
  • Overall obesity prevalence in CD patients was 45,000/100,000.
  • Obesity prevalence across all classes (I, II, III) showed a rising trend from 2014 to 2018.
  • Class I obesity was most prevalent, while Class II showed the highest increase.

Conclusions:

  • Obesity is an emerging comorbidity with increasing prevalence in celiac disease patients.
  • Clinicians must consider the rising rates of obesity when managing patients with CD longitudinally.

More Related Videos

Assessment of Child Anthropometry in a Large Epidemiologic Study09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.3K
Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography03:35

Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography

Published on: December 1, 2023

405

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
716
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
17
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
16
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
20
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
948
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
451